47
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Stimulant Psychosis: Symptom Profile and Acute Clinical Course

&
Pages 28-37 | Received 13 Jan 1999, Accepted 22 Jul 1999, Published online: 10 Jul 2009

  • Brady KT, Lydiard RB, Malcolm R, et al. Cocaineinduced psychosis. J Clin Psychiatry. 1991;52(12): 509-512.
  • MMWR. Increasing morbidity and mortality associated with abuse of methamphetamine-United States, 1991-1994. MMWR Mart" Mortal WkIy Rep. 1995;44(47):882-886.
  • Derlet RW, Rice P, Horowitz BZ, et al. Amphetamine toxicity: experience with 127 cases. J Emerg Med. 1989;7(2):157-161.
  • Lowenstein DH, Massa SM, Rowbotham MC, et al. Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med. 1987;83(5):841-846.
  • Rockwell DA, Ostwald P. Amphetamine use and abuse in psychiatric patients. Arch Gen Psychiatry. 1968;18:612-616.
  • Bell DS. A comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry. 1965;3:701.
  • Griffith JJ, Oates J, Cavanaugh J. Paranoid episodes induced by drugs. JAMA. 1968;205:39.
  • Slater E. Book review of 'Amphetamine Psychosis," by P. H. Connell. Br Med J. 1959;488.
  • Connell PH. Amphetamine Psychosis. Vol. 5. London: Oxford University Press; 1958.
  • Angrist B, Sathananthan G, WiIk S, et al. Amphetamine psychosis: behavioral and biochemical aspects. J Psycbiatr Res. 1974;11:13-23.
  • Janowsky DS, Risch C. Amphetamine psychosis and psychotic symptoms. Psychopharmacology. 1979;65:73-77.
  • Sato M, Chen CC, Akiyama K, et al. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry. 1983;18:429440.
  • Shaner A, Roberts LJ, Eckman TA, et al. Sources of diagnostic uncertainty for chronically psychotic cocaine abusers. Psychiatr Sew. 1998;49(5):684690.
  • Angrist B, Rotrosen J, Gershon S. Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology (Bert). 1980;72(1):17-19.
  • Angrist BM, Gershon S. The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biol Psychiatry. 1970; 2(2):95-107.
  • Janowsky DS, Davis JM. Methyiphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. Arch Gen Psychiatry. 1976;33(3):304-308.
  • Sato M. Experimental study of onset and relapsing mechanisms of chronic methamphetamine psychosis. Psychiatria et Neurologia Japonica. 1979; 81:21-32.
  • Flaum M, Schultz SK. When does amphetamineinduced psychosis become schizophrenia? Am J Psychiatry. 1996;153(6):812-815.
  • Sherer MA, Kumor KM, Crone EJ, et al. Suspiciousness induced by four-hour intravenous infusions of cocaine. Arch Gen Psychiatry. 1988;45: 673-677.
  • Palermo GB, Palermo MT. Clinical diagnostic considerations on cocaine abuse. J Psychoactive Drugs. 1990;22(3):313-318.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
  • Batki SL, Manfredi LB, Jacob PD, et al. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/ benzoylecgonine concentrations. J Clin Psychopharmacol. 1993;13(4):243-250.
  • Gawin FH, Kleber HD. Cocaine abuse treatment: open pilot trial with despiramine and lithium carbonate. Arch Gen Psychiatry. 1984;41:903-909.
  • First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department; 1995.
  • Kay SR, Fizbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizopbr Bull. 1987;13:261-276.
  • Overall JE, Gorham DR. The brief psychiatrie rating scale. Psychol Rep. 1962;10:799-812.
  • Gerlach J, Korsgaard S, Clemmesen P, et al. The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand. 1993;87(4):244-252.
  • Hollister LE. Clinical Use of Psychotherapeutic Drugs. Springfield, IL Charles C. Thomas; 1973.
  • Hayashi T, Tadokoro S. Parallelism between avoidance-suppressing and prolactin-increasing effects of antipsychotic drugs in rats. Jpn J Pharmacol. 1984;35:451-456.
  • Kay SR. Positive and Negative Syndromes in Schizophrenia: Assessment and Research. Vol. 5. New York: Brunner/Mazel; 1991.
  • Serper MR, Alpert M, Richardson NA, et al. Clinical effects of recent cocaine use on patients with acute schizophrenia. Am J Psychiatry. 1995; 152(10): 1464-1469.
  • Harris D, Wolkowitz O, Batki SL. Preliminary analysis of plasma cortisol in cocaine dependence: treatment with fluoxetine or placebo. In: Harris LS, ed. Problems of Drug Dependence 1995. Proceedings of the 57th Annual Scientific Meeting, the College on the Problems of Drug Dependence. NIDA Research Monograph Series. Scottsdale, Ariz: U.S. Government Printing Office; 1995.
  • Kennedy JA, Hartman N, Sbriglio R, et al. Metyrapone-induced withdrawal symptoms. Br J Addict. 1990;85(9):1133-1140.
  • Frederick SL, Reus VI, Ginsberg D, et al. Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biol Psychiatry. 1998, Apr 1; 43(7): 525-530.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.